236 related articles for article (PubMed ID: 11233900)
1. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.
Meier-Kriesche HU; Ojo AO; Leichtman AB; Magee JC; Rudich SM; Hanson JA; Cibrik DM; Kaplan B
Transplantation; 2001 Feb; 71(3):398-401. PubMed ID: 11233900
[TBL] [Abstract][Full Text] [Related]
2. Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.
Meier-Kriesche HU; Ojo AO; Leichtman AB; Punch JD; Hanson JA; Cibrik DM; Kaplan B
J Am Soc Nephrol; 2000 Dec; 11(12):2366-2370. PubMed ID: 11095660
[TBL] [Abstract][Full Text] [Related]
3. Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.
Kahu J; Lõhmus A; Ilmoja M; Kirsimägi U; Timberg G; Peetsalu A
Medicina (Kaunas); 2007; 43(12):953-8. PubMed ID: 18182839
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
Meier-Kriesche HU; Steffen BJ; Hochberg AM; Gordon RD; Liebman MN; Morris JA; Kaplan B
Transplantation; 2003 Apr; 75(8):1341-6. PubMed ID: 12717227
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Mycophenolate Mofetil Acute Renal Rejection Study Group
Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
[TBL] [Abstract][Full Text] [Related]
6. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
Meier-Kriesche HU; Morris JA; Chu AH; Steffen BJ; Gotz VP; Gordon RD; Kaplan B
Nephrol Dial Transplant; 2004 Nov; 19(11):2864-9. PubMed ID: 15496562
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
9. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
[TBL] [Abstract][Full Text] [Related]
10. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
Zhu B; Liu Z; Wu C; Wang P; Wang X; Xu H
Transplant Proc; 2008 Sep; 40(7):2258-61. PubMed ID: 18790207
[TBL] [Abstract][Full Text] [Related]
11. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
Ojo AO; Meier-Kriesche HU; Hanson JA; Leichtman AB; Cibrik D; Magee JC; Wolfe RA; Agodoa LY; Kaplan B
Transplantation; 2000 Jun; 69(11):2405-9. PubMed ID: 10868649
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
Triemer HL; Pearson TC; Odom KL; Larsen CP
Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
[TBL] [Abstract][Full Text] [Related]
14. Changing treatment protocol from azathioprine to mycophenolate mofetil: decrease in renal dysfunction, increase in infections.
Pourfarziani V; Panahi Y; Assari S; Moghani-Lankarani M; Saadat SH
Transplant Proc; 2007 May; 39(4):1237-40. PubMed ID: 17524943
[TBL] [Abstract][Full Text] [Related]
15. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Mathew TH
Transplantation; 1998 Jun; 65(11):1450-4. PubMed ID: 9645801
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
Knight SR; Russell NK; Barcena L; Morris PJ
Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
Schweitzer EJ; Yoon S; Fink J; Wiland A; Anderson L; Kuo PC; Lim JW; Johnson LB; Farney AC; Weir MR; Bartlett ST
Transplantation; 1998 Jan; 65(2):242-8. PubMed ID: 9458022
[TBL] [Abstract][Full Text] [Related]
18. New immunosuppressive treatment in kidney transplantation.
Di Landro D; Sarzo G; Marchini F
Clin Nephrol; 2000 Apr; 53(4):suppl 23-32. PubMed ID: 10809431
[TBL] [Abstract][Full Text] [Related]
19. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
20. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
Attallah N; Goggins M; Nori U; Abouljoud M; Zasuwa G; Venkat KK; Parasuraman R
Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]